CSIMarket
 


Stemline Therapeutics Inc  (STML)
Other Ticker:  
 

Stemline Therapeutics Inc's Quick Ratio

STML's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth




STML Quick Ratio (Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Current Liabilities Change -13.94 % 9.02 % 29.49 % 46.55 % 35.01 %
Y / Y Cash & cash equivalent Change 21.85 % 173.57 % 122.24 % 8.05 % 24.97 %
Quick Ratio MRQ 6.66 7.11 7.77 3.88 4.7
Overall Ranking # # # # #
Seq. Current Liabilities Change -1.62 % 3.05 % -16.23 % 1.34 % 24.62 %
Seq. Cash & cash equivalent Change -7.85 % -5.79 % 68.01 % -16.46 % 106.89 %



Quick Ratio first quarter 2020 Comment
Despite sequential decrease in Current Liabilities, Quick Ratio detoriated to 6.66 below company average Quick Ratio.

Within Major Pharmaceutical Preparations industry 78 other companies have achieved higher Quick Ratio than Stemline Therapeutics Inc in first quarter 2020. While total ranking remained unchanged compare to previous quarter at no. .

Explain Quick Ratio?
What are STML Segments?
See Quick Ratio STML on the trailing twelve month basis
Quick Ratio first quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 79
Healthcare Sector # 146
Overall Market # 289


Quick Ratio Statistics
High Average Low
30.75 8.29 2.61
(Sep 30 2013)   (Dec 31 2017)




Financial Statements
Stemline Therapeutics Inc's Current Liabilities $ 23 Millions Visit STML's Balance sheet
Stemline Therapeutics Inc's Cash & cash equivalent $ 152 Millions Visit STML's Balance sheet
Source of STML's Sales Visit STML's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2020, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2020 MRQ Cash & cash equivalentMar 31 2020 MRQ Current Liabilities
Revance Therapeutics Inc   18.31 $ 511.270  Millions$ 27.929  Millions
Viela Bio Inc   18.19 $ 314.830  Millions$ 17.309  Millions
Principia Biopharma Inc   17.28 $ 311.469  Millions$ 18.021  Millions
Synlogic Inc   16.75 $ 114.249  Millions$ 6.819  Millions
Oric Pharmaceuticals Inc   16.62 $ 79.442  Millions$ 4.780  Millions
Epizyme Inc   15.68 $ 376.461  Millions$ 24.004  Millions
Anaptysbio inc  15.59 $ 362.483  Millions$ 23.250  Millions
Kura Oncology Inc   14.91 $ 216.935  Millions$ 14.554  Millions
Cymabay Therapeutics Inc   14.78 $ 176.232  Millions$ 11.922  Millions
Diamedica Therapeutics Inc   14.61 $ 12.843  Millions$ 0.879  Millions
Glycomimetics Inc  14.59 $ 154.875  Millions$ 10.612  Millions
Intra cellular Therapies Inc   14.45 $ 448.954  Millions$ 31.076  Millions
Ideaya Biosciences Inc   14.24 $ 87.863  Millions$ 6.170  Millions
Trevena Inc  14.22 $ 28.090  Millions$ 1.975  Millions
Cytokinetics Inc  14.05 $ 220.706  Millions$ 15.711  Millions
Bridgebio Pharma Inc   13.94 $ 905.175  Millions$ 64.914  Millions
Seres Therapeutics Inc   13.60 $ 75.094  Millions$ 5.521  Millions
Savara Inc   13.58 $ 104.987  Millions$ 7.729  Millions
Apellis Pharmaceuticals inc   13.47 $ 646.694  Millions$ 48.008  Millions
Rocket Pharmaceuticals Inc   13.07 $ 275.895  Millions$ 21.114  Millions
Marker Therapeutics Inc   12.74 $ 40.300  Millions$ 3.164  Millions
Adial Pharmaceuticals Inc   12.70 $ 4.952  Millions$ 0.390  Millions
Hepion Pharmaceuticals Inc   12.67 $ 16.000  Millions$ 1.263  Millions
Mirati Therapeutics Inc   12.54 $ 695.360  Millions$ 55.450  Millions
Sage Therapeutics Inc   12.40 $ 872.757  Millions$ 70.360  Millions
Kala Pharmaceuticals Inc   12.36 $ 196.456  Millions$ 15.898  Millions
Aravive Inc   12.24 $ 60.700  Millions$ 4.959  Millions
Catabasis Pharmaceuticals Inc  12.01 $ 55.103  Millions$ 4.590  Millions
Vanda Pharmaceuticals Inc   11.99 $ 312.326  Millions$ 26.045  Millions
Mirum Pharmaceuticals Inc   11.78 $ 159.531  Millions$ 13.548  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

EVRI's Profile

Stock Price

EVRI's Financials

Business Description

Fundamentals

Charts & Quotes

EVRI's News

Suppliers

EVRI's Competitors

Customers & Markets

Economic Indicators

EVRI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071